Elevance Health, a prominent health insurer, recently announced a downward revision of its profit forecast for the remainder of 2025. This adjustment is attributed to the escalating costs associated with its Medicaid plans and individual policies under the Affordable Care Act. The company anticipates that its adjusted net income per diluted share will be approximately $30.00, a decrease from its earlier projection of $34.15 to $34.85.
As the second largest health insurer in the country, Elevance Health operates Anthem brand Blue Cross and Blue Shield plans in 14 states. The company also manages Medicaid programs in multiple states and offers individual coverage through the ACA. Additionally, Elevance has a growing Carelon healthcare services business.
In response to the challenges posed by rising healthcare costs, Gail K. Boudreaux, the president and CEO of Elevance, emphasized the company’s commitment to managing expenses, investing in advanced technology, and enhancing value-based care delivery. Despite the current obstacles, Elevance remains confident in achieving a 12% average annual growth in adjusted diluted EPS over time.
The financial struggles faced by Elevance Health are reflective of a broader trend within the health insurance industry. Centene recently withdrew its 2025 financial guidance due to increased costs in individual health plans and Medicaid programs. Similarly, Molina Healthcare and UnitedHealth have also adjusted their earnings forecasts in response to mounting cost pressures.
In the second quarter, Elevance reported a 24% decrease in net income, primarily driven by rising costs. The company’s benefit expense ratio, which represents the percentage of premium revenue allocated towards medical costs, increased to 88.9%. Despite these challenges, Elevance’s health benefits segment experienced a 12% growth in operating revenue, driven by higher premium yields and acquisitions.
On the other hand, Elevance’s Carelon health services business witnessed a 36% increase in operating revenue, reaching $18.1 billion in the second quarter. This growth was fueled by acquisitions in home health and pharmacy services, as well as the expansion of innovative risk-based capabilities.
In conclusion, Elevance Health’s revised profit forecast underscores the ongoing struggles faced by health insurers in managing escalating healthcare costs. By focusing on cost management, technological investments, and value-based care delivery, Elevance aims to navigate these challenges and sustain long-term value creation.
